Although transplanting mesenchymal stem cells can improve cardiac function and contribute to endothelial recovery in a damaged artery, mesenchymal stem cells may induce neointimal hyperplasia by directly or indirectly acting on vascular smooth muscle cells. Receptor activity-modifying protein 1 is the specificity receptors of calcitonin gene-related peptide. calcitonin gene-related peptide and its receptor involve the proliferation and the apoptosis in vivo and in vitro, exogenous receptor activity-modifying protein 1 enhances the antiproliferation effect of calcitonin gene-related peptide in vascular smooth muscle cells.
Bei Shi, Xianping Long, Ranzun Zhao, Zhijiang Liu, Dongmei Wang and Guanxue Xu, researchers at the First Affiliated Hospital of Zunyi Medical College within the Guizhou Province of China, have reported an approach for improving the use of stem cells for improvement of infarcted heart function and damage to the arteries in the March 2013 issue of Experimental Biology and Medicine. They have discovered that mesenchymal stem cells (MSCs) transfected with a recombinant adenovirus containing the human receptor activity-modifying protein 1 (hRAMP1) gene (EGFP-hRAMP1-MSCs) when transplanted into rabbit models for both Myocardial infarction (MI) and carotid artery injury inhibit vascular smooth muscle cell (VSMC) proliferation within the neointima, and greatly improved both infarcted heart function and endothelial recovery from artery injury more efficiently than the control EGFP-MSCs.
MSCs have good applicability for cell transplantation because they possess self-renewal and multiple differentiation potential. With addition of either environmental or chemical substances, MSCs can differentiate into a variety of cell types. Numerous animal experiments and small clinical trials have shown that MSC transplantation can promote the formation of new blood vessels and reduce myocardial infarct size, and diminish the formation of scar tissue and ventricular remodeling, and improve cardiac functions. Nevertheless, MSCs have the potential to differentiate into VSMCs and may be the source of proliferating VSMCs during neointima formation after vascular injury. Recently, genetically modified MSCs, such as heme oxygenase-1(HO-1), granulocyte colony-stimulating factor (G-CSF) over-expressing MSCs, have proven to be more efficient at ameliorating infarcted myocardium than administering MSCs alone.
Calcitonin gene related protein (CGRP) is one of the most well-known potent vasodilators and can regulate vascular tone and other aspects of vascular function. The receptors for CGRP include the calcitonin receptor-like receptor (CRLR), RAMP1, and the receptor component protein. RAMP1 confers ligand specificity for CGRP. The relaxation of the artery in response to CGRP is dependent on RAMP1 expression. The response to CGRP is augmented after the increased expression of RAMP1 in VSMCs in culture.
RAMP1 over-expression increased CGRP-induced vasodilation and protected against angiotensin II-induced endothelial dysfunction as well as prevented VSMCs proliferation. In this study, we tested the effects of human RAMP1-over-expressing MSCs on infarcted heart function and intimal hyperplasia by means of cell transplantation in rabbit models for MI reperfusion and carotid artery injury. Bei Shi said "Our data has shown that hRAMP1 over-expression in MSCs through genetic modification significantly inhibits neointimal proliferation and improves infarcted heart function."
Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said "The effect of stem cell therapy with the RAMP1 expressing MSCs has been shown, by Bei Shi and colleagues, to reduce neointimal proliferation in the carotid angioplasty and myocardial infarction animal models. This approach could be important for the treatment of damaged vessels and the infracted heart".
Explore further: Screening for transformed human mesenchymal stromal cells with tumorigenic potential
Medical Xpress on facebook
Related Stories
Screening for transformed human mesenchymal stromal cells with tumorigenic potential
Jan 29, 2014
Researchers at Erasmus University Medical Center Rotterdam, The Netherlands, led by Dr. Qiuwei Pan and Dr. Luc van der Laan, have discovered that spontaneous tumorigenic transformation of human mesenchymal stem/stromal cells ...
Liver cells benefit from mesenchymal stem cell co-culture prior to transplantation
Dec 18, 2013
Hepatocyte (liver cell) transplantation is becoming an accepted therapy for acute liver failure, either for liver regeneration or as a bridge to liver transplantation. However, maintaining the viability and functional aspects ...
Melatonin pre-treatment is a factor that impacts stem cell survival after transplantation
Jul 22, 2013
When melatonin, a hormone secreted by the pineal gland, was used as a pre-treatment for mesenchymal stem cells (MSCs) prior to their transplantation into the brains of laboratory animals to repair damage from stroke, researchers ...
Stem cell source an important factor, impacting ability to treat myocardial infarction
Feb 13, 2013
When a research team from Denmark and Sweden compared the therapeutic capabilities of adipose-derived stem cells (ASCs) versus bone marrow-derived stem cells (BMSCs) obtained from a single 84 year-old male donor with ischemic ...
Scientists identify protein that may promote migraines
Mar 08, 2007
A University of Iowa study may provide an explanation for why some people get migraine headaches while others do not. The researchers found that too much of a small protein called RAMP1 appears to "turn up the volume" of ...
Recommended for you
New therapeutic target identified for acute lung injury
55 minutes ago
A bacterial infection can throw off the equilibrium between two key proteins in the lungs and put patients at risk for a highly lethal acute lung injury, researchers report.
Shaped scaffolding helps repair mandibular bone
4 hours ago
A new invention made at the Faculty of Dentistry, University of Oslo, Norway, helps the body generate new bone which is as strong as the original.
Sepsis study comparing three treatment methods shows same survival rate
9 hours ago
Survival of patients with septic shock was the same regardless of whether they received treatment based on specific protocols or the usual high-level standard of care, according to a five-year clinical study. The large-scale ...
Baby's life saved after 3D printed devices were implanted at U-M to restore his breathing
18 hours ago
In his 18 months of life, Garrett Peterson has never gone home, spending his days in hospital beds tethered to ventilators that even at the highest settings couldn't prevent his breathing from periodically ...
Eat more, die young: Why eating a diet very low in nutrients can extend lifespan
19 hours ago
A new evolutionary theory in BioEssays claims that consuming a diet very low in nutrients can extend lifespan in laboratory animals, a finding which could hold clues to promoting healthier ageing in humans.
Biomarkers provide potential for better preeclampsia detection
20 hours ago
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) ...
User comments
© Medical Xpress 2011-2014, Science X network
Although transplanting mesenchymal stem cells can improve cardiac function and contribute to endothelial recovery in a damaged artery, mesenchymal stem cells may induce neointimal hyperplasia by directly or indirectly acting on vascular smooth muscle cells. Receptor activity-modifying protein 1 is the specificity receptors of calcitonin gene-related peptide. calcitonin gene-related peptide and its receptor involve the proliferation and the apoptosis in vivo and in vitro, exogenous receptor activity-modifying protein 1 enhances the antiproliferation effect of calcitonin gene-related peptide in vascular smooth muscle cells.
Bei Shi, Xianping Long, Ranzun Zhao, Zhijiang Liu, Dongmei Wang and Guanxue Xu, researchers at the First Affiliated Hospital of Zunyi Medical College within the Guizhou Province of China, have reported an approach for improving the use of stem cells for improvement of infarcted heart function and damage to the arteries in the March 2013 issue of Experimental Biology and Medicine. They have discovered that mesenchymal stem cells (MSCs) transfected with a recombinant adenovirus containing the human receptor activity-modifying protein 1 (hRAMP1) gene (EGFP-hRAMP1-MSCs) when transplanted into rabbit models for both Myocardial infarction (MI) and carotid artery injury inhibit vascular smooth muscle cell (VSMC) proliferation within the neointima, and greatly improved both infarcted heart function and endothelial recovery from artery injury more efficiently than the control EGFP-MSCs.
MSCs have good applicability for cell transplantation because they possess self-renewal and multiple differentiation potential. With addition of either environmental or chemical substances, MSCs can differentiate into a variety of cell types. Numerous animal experiments and small clinical trials have shown that MSC transplantation can promote the formation of new blood vessels and reduce myocardial infarct size, and diminish the formation of scar tissue and ventricular remodeling, and improve cardiac functions. Nevertheless, MSCs have the potential to differentiate into VSMCs and may be the source of proliferating VSMCs during neointima formation after vascular injury. Recently, genetically modified MSCs, such as heme oxygenase-1(HO-1), granulocyte colony-stimulating factor (G-CSF) over-expressing MSCs, have proven to be more efficient at ameliorating infarcted myocardium than administering MSCs alone.
Calcitonin gene related protein (CGRP) is one of the most well-known potent vasodilators and can regulate vascular tone and other aspects of vascular function. The receptors for CGRP include the calcitonin receptor-like receptor (CRLR), RAMP1, and the receptor component protein. RAMP1 confers ligand specificity for CGRP. The relaxation of the artery in response to CGRP is dependent on RAMP1 expression. The response to CGRP is augmented after the increased expression of RAMP1 in VSMCs in culture.
RAMP1 over-expression increased CGRP-induced vasodilation and protected against angiotensin II-induced endothelial dysfunction as well as prevented VSMCs proliferation. In this study, we tested the effects of human RAMP1-over-expressing MSCs on infarcted heart function and intimal hyperplasia by means of cell transplantation in rabbit models for MI reperfusion and carotid artery injury. Bei Shi said "Our data has shown that hRAMP1 over-expression in MSCs through genetic modification significantly inhibits neointimal proliferation and improves infarcted heart function."
Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said "The effect of stem cell therapy with the RAMP1 expressing MSCs has been shown, by Bei Shi and colleagues, to reduce neointimal proliferation in the carotid angioplasty and myocardial infarction animal models. This approach could be important for the treatment of damaged vessels and the infracted heart".
Explore further: Screening for transformed human mesenchymal stromal cells with tumorigenic potential
Medical Xpress on facebook
Related Stories
Screening for transformed human mesenchymal stromal cells with tumorigenic potential
Jan 29, 2014
Researchers at Erasmus University Medical Center Rotterdam, The Netherlands, led by Dr. Qiuwei Pan and Dr. Luc van der Laan, have discovered that spontaneous tumorigenic transformation of human mesenchymal stem/stromal cells ...
Liver cells benefit from mesenchymal stem cell co-culture prior to transplantation
Dec 18, 2013
Hepatocyte (liver cell) transplantation is becoming an accepted therapy for acute liver failure, either for liver regeneration or as a bridge to liver transplantation. However, maintaining the viability and functional aspects ...
Melatonin pre-treatment is a factor that impacts stem cell survival after transplantation
Jul 22, 2013
When melatonin, a hormone secreted by the pineal gland, was used as a pre-treatment for mesenchymal stem cells (MSCs) prior to their transplantation into the brains of laboratory animals to repair damage from stroke, researchers ...
Stem cell source an important factor, impacting ability to treat myocardial infarction
Feb 13, 2013
When a research team from Denmark and Sweden compared the therapeutic capabilities of adipose-derived stem cells (ASCs) versus bone marrow-derived stem cells (BMSCs) obtained from a single 84 year-old male donor with ischemic ...
Scientists identify protein that may promote migraines
Mar 08, 2007
A University of Iowa study may provide an explanation for why some people get migraine headaches while others do not. The researchers found that too much of a small protein called RAMP1 appears to "turn up the volume" of ...
Recommended for you
New therapeutic target identified for acute lung injury
55 minutes ago
A bacterial infection can throw off the equilibrium between two key proteins in the lungs and put patients at risk for a highly lethal acute lung injury, researchers report.
Shaped scaffolding helps repair mandibular bone
4 hours ago
A new invention made at the Faculty of Dentistry, University of Oslo, Norway, helps the body generate new bone which is as strong as the original.
Sepsis study comparing three treatment methods shows same survival rate
9 hours ago
Survival of patients with septic shock was the same regardless of whether they received treatment based on specific protocols or the usual high-level standard of care, according to a five-year clinical study. The large-scale ...
Baby's life saved after 3D printed devices were implanted at U-M to restore his breathing
18 hours ago
In his 18 months of life, Garrett Peterson has never gone home, spending his days in hospital beds tethered to ventilators that even at the highest settings couldn't prevent his breathing from periodically ...
Eat more, die young: Why eating a diet very low in nutrients can extend lifespan
19 hours ago
A new evolutionary theory in BioEssays claims that consuming a diet very low in nutrients can extend lifespan in laboratory animals, a finding which could hold clues to promoting healthier ageing in humans.
Biomarkers provide potential for better preeclampsia detection
20 hours ago
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment